review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Pradeep Tyagi | Q87291375 |
P2093 | author name string | Jonathan Kaufman | |
Naoki Yoshimura | |||
Chan-Hong Moon | |||
Michael Chancellor | |||
Christopher Chermansky | |||
Joseph Janicki | |||
P2860 | cites work | Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis | Q73286098 |
Tiaprofenic acid: an uncommon cause of cystitis often misdiagnosed as interstitial cystitis | Q73382902 | ||
[In vitro study of morphology of the bladder wall using MR tomography at 1.0 Tesla: correlation with histology] | Q73448278 | ||
[The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging] | Q74074860 | ||
Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model | Q74549228 | ||
Determining the displacement of the pelvic floor and pelvic organs during voluntary contractions using magnetic resonance imaging in younger and older women | Q74603198 | ||
HUNNER'S ULCER (CHRONIC INTERSTITIAL CYSTITIS). A MANIFESTATION OF COLLAGEN DISEASE | Q78557758 | ||
The Principle of Nuclear Induction | Q81231118 | ||
Magnetic resonance voiding cystography in the diagnosis of vesicoureteral reflux: comparative study with voiding cystourethrography | Q81547847 | ||
Tumour pathology of the bladder: the role of MRI | Q83781872 | ||
Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome | Q83932618 | ||
Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome | Q83947318 | ||
Novel approach to segment the inner and outer boundaries of the bladder wall in T2-weighted magnetic resonance images | Q84074872 | ||
Investigation of a Ca2+ channel α2δ ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial | Q84593874 | ||
Transabdominal ultrasound measurement of pelvic floor muscle mobility in men with and without chronic prostatitis/chronic pelvic pain syndrome | Q84877821 | ||
YKL‐40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis | Q85029171 | ||
Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study | Q85357456 | ||
Correlation of cystoscopically confirmed periureterally located hunner lesion with vesicoureteral reflux: preliminary study in patients with interstitial cystitis | Q86966040 | ||
Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Low Energy Shock Waves | Q87003583 | ||
Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection | Q87154872 | ||
Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C | Q87844273 | ||
Endoscopic Injection of Low Dose Triamcinolone: A Simple, Minimally Invasive, and Effective Therapy for Interstitial Cystitis With Hunner Lesions | Q88757995 | ||
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study | Q88815070 | ||
Ultrasound distinction between simple recurrent urinary tract infections and a specific bladder wall inflammatory entity called cystitis cystica | Q95380502 | ||
Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder | Q26774233 | ||
Evaluation of brain edema using magnetic resonance proton relaxation times | Q30662713 | ||
Optical-based molecular imaging: contrast agents and potential medical applications | Q30888936 | ||
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths | Q31011793 | ||
Chemical shift: the artifact and clinical tool revisited | Q33178088 | ||
Endogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis | Q33662383 | ||
Quantitative relaxometry of the brain | Q33912467 | ||
Mast cell involvement in interstitial cystitis: a review of human and experimental evidence | Q34264766 | ||
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment | Q34459826 | ||
Bladder surface glycosaminoglycans: an epithelial permeability barrier | Q34569586 | ||
Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study | Q34723373 | ||
Shedding light onto live molecular targets | Q35039563 | ||
Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. | Q35078389 | ||
Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis | Q35110940 | ||
Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis/painful bladder syndrome | Q35609893 | ||
Increased brain gray matter in the primary somatosensory cortex is associated with increased pain and mood disturbance in patients with interstitial cystitis/painful bladder syndrome | Q35619417 | ||
Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation | Q35846928 | ||
Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation | Q35902842 | ||
Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model | Q36444518 | ||
Edge artifacts in MR images: chemical shift effect | Q36493808 | ||
Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome. | Q36584825 | ||
Water proton relaxation times: main parameters in nuclear magnetic resonance medical diagnosis | Q36587274 | ||
A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis | Q36599064 | ||
Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. | Q36860034 | ||
Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer. | Q36899066 | ||
Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens | Q36907584 | ||
Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis | Q36907771 | ||
Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion. | Q48297020 | ||
Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging | Q48448343 | ||
New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system | Q48460585 | ||
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients | Q48636328 | ||
Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. | Q51643744 | ||
[The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?] | Q53029087 | ||
3D detection and extraction of bladder tumors via MR virtual cystoscopy. | Q53203593 | ||
Urinary bladder MR imaging. Part I. Normal and benign conditions. | Q53711606 | ||
Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. | Q55345274 | ||
Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion. | Q55514787 | ||
T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease | Q56027588 | ||
Partial cystectomy for the myogenic decompensated bladder with excessive residual urine. Urodynamics, histology and 2-13 years follow-up | Q68053761 | ||
Pseudolayering of Gd-DTPA in the urinary bladder | Q68695593 | ||
Bladder wall morphology: in vitro MR imaging-histopathologic correlation | Q70604691 | ||
Permeability and ultrastructure of human bladder epithelium | Q71062445 | ||
Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis | Q71062449 | ||
Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer | Q71072923 | ||
Increased number of substance P positive nerve fibres in interstitial cystitis | Q71701734 | ||
Detection of muscle layer invasion with submillimeter pixel MR images: staging of bladder carcinoma | Q72649012 | ||
Bladder permeability in interstitial cystitis is similar to that of normal volunteers: direct measurement by transvesical absorption of 99mtechnetium-diethylenetriaminepentaacetic acid | Q72713066 | ||
Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement | Q72992892 | ||
Performance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequence | Q36977504 | ||
Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis. | Q37034930 | ||
Elevated level of nerve growth factor in the bladder pain syndrome/interstitial cystitis: a meta-analysis | Q37092523 | ||
Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome | Q37250416 | ||
Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis | Q37330013 | ||
Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells | Q37421999 | ||
The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study | Q37489944 | ||
Urinary bladder cancer: role of MR imaging | Q37993016 | ||
Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials | Q38079516 | ||
Recommendations for the Diagnosis and Management of Bladder Pain Syndrome. Spanish Urological Association Consensus Document | Q38508614 | ||
The Role of Glomerulations in Bladder Pain Syndrome: A Review | Q38576183 | ||
Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis: A Retrospective Claims Analysis | Q38874613 | ||
A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society | Q38937743 | ||
Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome | Q38959550 | ||
MRI suggests increased tonicity of the levator ani in women with interstitial cystitis/bladder pain syndrome | Q38978971 | ||
Motion correction for MR cystography by an image processing approach | Q39434225 | ||
Inflammatory cell types and clinical features of interstitial cystitis | Q39453623 | ||
A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma | Q39717326 | ||
Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy | Q39819685 | ||
Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study | Q40108877 | ||
Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients | Q40215366 | ||
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. | Q40447909 | ||
Optical diagnosis of lower urinary tract infection: a pilot study in children | Q41406767 | ||
Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis | Q41491960 | ||
Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? | Q41570906 | ||
Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes | Q41588497 | ||
The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis | Q42151852 | ||
Targeting afferent hyperexcitability for therapy of the painful bladder syndrome | Q42676259 | ||
Bladder outlet obstruction: progression from inflammation to fibrosis. | Q42999420 | ||
Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). | Q44210421 | ||
Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome | Q44272905 | ||
Clinical value of pelvic 3-dimensional magnetic resonance image reconstruction in anorectal malformations | Q44466184 | ||
A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome | Q44688690 | ||
Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure | Q45037314 | ||
The histology of interstitial cystitis | Q45110085 | ||
Development of an interstitial cystitis risk score for bladder permeability. | Q45948914 | ||
Bladder surface glycosaminoglycans is a human epithelial permeability barrier. | Q45949629 | ||
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging | Q46390716 | ||
Novel contrast mixture improves bladder wall contrast for visualizing bladder injury | Q47314030 | ||
Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. | Q47316195 | ||
Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study | Q47379554 | ||
Novel contrast mixture achieves contrast resolution of human bladder wall suitable for T1 mapping: applications in interstitial cystitis and beyond | Q47547120 | ||
Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. | Q47960362 | ||
Activation of the mTOR dependent signaling pathway underlies ketamine-induced uropathy | Q47964319 | ||
Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. | Q48054557 | ||
Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome. | Q48132162 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interstitial cystitis | Q1671412 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 1771 | |
P577 | publication date | 2018-11-09 | |
P1433 | published in | F1000Research | Q27701587 |
P1476 | title | Recent advances in imaging and understanding interstitial cystitis | |
P478 | volume | 7 |
Search more.